Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma

Oncology

Volumn 82, Issue 1, 2012, Pages 35-40

  Agúndez, José A ^a   García Martín, Elena ^a   Devesa, María J ^b   Carballo, Miguel ^d   Martínez, Carmen ^a   Lee Brunner, Anna ^b   Fernández, Cristina ^c   Díaz Rubio, Manuel ^b   Ladero, José M ^b  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d HOSPITAL DE TERRASSA   (Spain)

Author keywords

Genetic polymorphism; Hepatitis C virus; Hepatocellular carcinoma; Toll like receptor 4

Indexed keywords

TOLL LIKE RECEPTOR 4;

ADULT; ARTICLE; CAUCASIAN; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STAGING; TUMOR GENE;

AGED; ALLELES; CARCINOMA, HEPATOCELLULAR; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; GENOTYPE; HEPATITIS C; HETEROZYGOTE; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SPAIN; TOLL-LIKE RECEPTOR 4;

EID: 84856177508     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000335606     Document Type: Article

References (27)

1. Franceschi S, Raza SA: Epidemiology and prevention of hepatocellular carcinoma. Cancer Lett 2009; 286: 5-8.
2. Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD: Hepatocellular carcinoma: Epidemiology, risks factors and pathogenesis. World J Gastroenterol 2008; 21: 4300-4308.
3. Chuang SC, La Vecchia C, Boffetta P: Liver cancer: Descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett 2009; 286: 9-14.
4. Poynard T, Bedossa P, Opolon P: Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349: 825-832. (Pubitemid 27129209)
5. Seeff LB: Natural history of chronic hepatitis C. Hepatology 2002; 36:S35-S46. (Pubitemid 35253462)
6. Dragani TA: Risk of HCC: Genetic heterogeneity and complex genetics. J Hepatol 2009; 52: 252-257.
7. Turvey SE, Hawn TR: Towards subtlety: Understanding the role of Toll-like receptor signalling in susceptibility to human infections. Clin Immunol 2006; 120: 1-9. (Pubitemid 43903389)
8. Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 2003; 21: 335-376. (Pubitemid 37174535)
9. Georgel P, Macquin C, Bahram S: The heterogeneous allelic repertoire of human Tolllike receptors (TLR) genes. PLos ONE 2009; 11:e7803.
10. Misch EA, Hawn TR: Toll-like receptor polymorphisms and susceptibility to human disease. Clin Sci 2008; 114: 347-360. (Pubitemid 351397384)
11. Chen C, Kono H, Galenbock D, Reed G, Akira S, Rock KL: Identification of a key pathway required for sterile inflammatory response triggered by dying cells. Nat Med 2007; 13: 851-856. (Pubitemid 47038190)
12. Seki E, De Minicis S, Österreicher CH, Kluwe J, Osawa Y, Brenner DA, Schwabe RF: TLR4 enhances TGF- signaling and hepatic fibrosis. Nat Med 2007; 13: 1324-1332. (Pubitemid 350073596)
13. Guo J, Friedman SL: Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis. Fibrogenesis Tissue Rep 2010; 3: 21.
14. Ferwerda B, McCall MB, Verheijen K, Kullberg BJ, van der Ven AJ, Van Der Meer JW, Netea MG: Functional consequences of Tolllike receptor 4 polymorphisms. Mol Med 2008; 14: 346-352. (Pubitemid 351785708)
15. Kutikhin A: Impact of Toll-like receptor 4 polymorphisms on risk of cancer. Hum Immunol 2011; 72: 193-206.
16. Minmin S, Xiaoqian X, Hao C: Single nucleotide polymorphism of Toll-like receptor 4 decrease the risk of development of hepatocellular carcinoma. PLos ONE 2011; 6: E19466.
17. Lencioni R: Evolving strategies in the diagnosis of hepatocellular carcinoma. J Hepatol 2011; 54: 184-186.
18. Donato F, Tagger A, Gelatti U, Parrinello G, Boffetta P, Albertini A, Decarli A, Trevisi P, Ribero ML, Martelli C, Porru S, Nardi G: Alcohol and hepatocellular carcinoma: The effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 2002; 155: 323-331. (Pubitemid 34132050)
19. Pons F, Varela M, Llovet JM: Staging systems in hepatocellular carcinoma. HPB (Oxford) 2005; 7: 35-41. (Pubitemid 40425755)
20. The French METAVIR Cooperative Study Group: Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15-20.
21. The Spanish Association for the Study of the Liver: Consensus document of the Spanish Association for the Study of the Liver on the treatment of hepatitis B and C virus infection. Gastroenterol Hepatol 2006; 29(suppl 2):216-230.
22. Singal AG, Volk ML, Jensen D, Di Bisceglie AM, Schoenfeld PS: A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus. Clin Gastroenterol Hepatol 2010; 8: 280-288.
23. Trapero-Marugán M, Mendoza J, Chaparro M, González-Moreno L, Moreno-Monteagudo JA, Borque MJ, Moreno-Otero R: Long-term outcome of chronic hepatitis C patients with sustained virological response to interferon plus ribavirin. World J Gastroenterol 2011; 17: 493-498.
24. Guo J, Loke J, Zheng F, Hong F, Yea S, Fukata M, Tarocchi M, Abar OT, Huang H, Sninsky JJ, Friedman SL: Functional linkage of cirrhosis-predictive single nucleotide polymorphism of toll-like receptor 4 to hepatic stellate cell responses. Hepatology 2009; 49: 960-968.
25. Srivastava K, Srivastava A, Kumar A, Mittal B: Significant association between Toll-like receptor gene polymorphism and gallbladder cancer. Liver Int 2010; 30: 1067-1072.
26. Sharma NK, Sherker AH: Epidemiology, risk factors, and natural history of chronic hepatitis C; in Shetty K, Wu GY (eds): Clinical Gastroenterology: Chronic Viral Hepatitis. New York, Humana Press, 2009, pp 33-70.
27. González-Pino A, Mañas N, Tejero M, Ladero JM, Díaz-Rubio M: Resultado de un programa de cribado para la detección precoz de carcinoma hepatocelular en enfermos hepatópatas crónicos (abstract). Rev Esp Enferm Dig 2010; 19(suppl 1):39.